MannKind Corp (MNKD)
6.90
+0.02
(+0.29%)
USD |
NASDAQ |
Nov 21, 16:00
6.95
+0.05
(+0.72%)
After-Hours: 20:00
MannKind Enterprise Value: 1.879B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.879B |
| November 20, 2024 | 1.874B |
| November 19, 2024 | 1.868B |
| November 18, 2024 | 1.830B |
| November 15, 2024 | 1.852B |
| November 14, 2024 | 1.912B |
| November 13, 2024 | 1.896B |
| November 12, 2024 | 1.929B |
| November 11, 2024 | 1.967B |
| November 08, 2024 | 2.002B |
| November 07, 2024 | 2.014B |
| November 06, 2024 | 2.028B |
| November 05, 2024 | 1.978B |
| November 04, 2024 | 1.932B |
| November 01, 2024 | 1.954B |
| October 31, 2024 | 1.926B |
| October 30, 2024 | 1.912B |
| October 29, 2024 | 1.871B |
| October 28, 2024 | 1.857B |
| October 25, 2024 | 1.780B |
| October 24, 2024 | 1.752B |
| October 23, 2024 | 1.766B |
| October 22, 2024 | 1.807B |
| October 21, 2024 | 1.802B |
| October 18, 2024 | 1.796B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.796B |
| October 16, 2024 | 1.832B |
| October 15, 2024 | 1.799B |
| October 14, 2024 | 1.780B |
| October 11, 2024 | 1.763B |
| October 10, 2024 | 1.719B |
| October 09, 2024 | 1.750B |
| October 08, 2024 | 1.758B |
| October 07, 2024 | 1.725B |
| October 04, 2024 | 1.766B |
| October 03, 2024 | 1.747B |
| October 02, 2024 | 1.711B |
| October 01, 2024 | 1.703B |
| September 30, 2024 | 1.711B |
| September 27, 2024 | 1.685B |
| September 26, 2024 | 1.704B |
| September 25, 2024 | 1.737B |
| September 24, 2024 | 1.765B |
| September 23, 2024 | 1.773B |
| September 20, 2024 | 1.795B |
| September 19, 2024 | 1.822B |
| September 18, 2024 | 1.811B |
| September 17, 2024 | 1.784B |
| September 16, 2024 | 1.781B |
| September 13, 2024 | 1.704B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
248.36M
Minimum
Mar 16 2020
2.028B
Maximum
Nov 06 2024
1.054B
Average
1.133B
Median
May 08 2023
Enterprise Value Benchmarks
| Mirum Pharmaceuticals Inc | 2.110B |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 11.55M |
| Revenue (Quarterly) | 70.08M |
| Total Expenses (Quarterly) | 54.86M |
| EPS Diluted (Quarterly) | 0.04 |
| Gross Profit Margin (Quarterly) | 74.28% |
| Profit Margin (Quarterly) | 16.48% |
| Earnings Yield | 1.16% |
| Operating Earnings Yield | 2.88% |
| Normalized Earnings Yield | 1.473 |